This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2017 May 25;376(21):2075-2076.

doi: 10.1056/NEJMe1702205.

Cannabinoids for Epilepsy - Real Data, at Last

Samuel F Berkovic¹

Affiliations

PMID: 28538129
DOI: 10.1056/NEJMe1702205

Editorial

Cannabinoids for Epilepsy - Real Data, at Last

Samuel F Berkovic. N Engl J Med. 2017.

. 2017 May 25;376(21):2075-2076.

doi: 10.1056/NEJMe1702205.

Author

Samuel F Berkovic¹

Affiliation

¹ From the Epilepsy Research Centre, University of Melbourne at Austin Health, Heidelberg, VIC, Australia.

PMID: 28538129
DOI: 10.1056/NEJMe1702205

No abstract available

PubMed Disclaimer

Comment on

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.
Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, Scheffer IE, Thiele EA, Wright S; Cannabidiol in Dravet Syndrome Study Group. Devinsky O, et al. N Engl J Med. 2017 May 25;376(21):2011-2020. doi: 10.1056/NEJMoa1611618. N Engl J Med. 2017. PMID: 28538134 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information